Crescent Biopharma

CBIO · NASDAQ

$13.07+$0.71 (+5.74%)TodayMarket closed ·
Prev close $12.36

Who owns CBIO

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 61.6% of CBIO’s shares.

  • Fidelity Management & Research Company LLC11.6%
  • Fairmount Funds Management LLC10.1%
  • BVF Partners L.P.7.7%
  • VR Adviser, LLC6.0%
  • Next 6 largest institutions26.2%
  • All other shareholders38.4%
Top institutional holders of CBIO
HolderShares% of shares
Fidelity Management & Research Company LLC4.13M11.59%
Fairmount Funds Management LLC3.60M10.10%
BVF Partners L.P.2.75M7.71%
VR Adviser, LLC2.13M5.98%
Logos Global Management LP1.90M5.33%
Forbion Capital Partners1.68M4.70%
Balyasny Asset Management LP1.66M4.66%
Vestal Point Capital, LP1.63M4.57%
Opaleye Management Inc.1.32M3.70%
Tang Capital Management, LLC1.16M3.25%

Largest mutual fund holders

Top mutual fund holders of CBIO
HolderShares% of shares
Vanguard Total Stock Market Index Fund906.65K2.54%
iShares Russell 2000 ETF538.07K1.51%
Fidelity Advisor Biotechnology Fund356.09K1.00%
PGIM Jennison Health Sciences Fund311.39K0.87%
Fidelity Select Health Care Portfolio301.85K0.85%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $20.00M (2 trades) and sold $1.51M (16 trades) of CBIO on the open market.

Latest CBIO insider transactions
InsiderTypeSharesValue
Brumm Joshua TSale7.84K$130.96K
McNeill JonathanSale3.84K$64.15K
Lynch RyanSale240$4.30K
Pinkas JanSale658$11.78K
Im Ellie EunkyungSale623$11.15K
Scalzo Richard WilliamSale568$10.17K
Bispham Barbara HarlinSale620$11.10K
Brumm Joshua TSale1.61K$28.82K
McNeill JonathanSale731$13.08K
Fairmount Funds Management LLCBuy525.90K$7.62M

Short interest

Settled Sep 30, 2026

Shares short
4.78M
Days to cover
6.85
% of shares outstanding
13.39%
Average daily volume
697.40K
Change since last report
+40.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.